Factors Influencing Outcomes in ECMO and Impella Patients
Official title: Investigation of Factors Influencing Outcomes in Patients Requiring ECMO and Impella Support, With Special Focus on Their Metabolic and Thyroid Hormone Changes (Az ECMO és Impella kezelést igénylő Betegek kimenetelét befolyásoló tényezők vizsgálata, különös Tekintettel Metabolikus és Pajzsmirigyhormon változásaikra)
Run by Gottsegen National Cardiovascular Institute · NCT07885618 · Data updated 2026-11-12
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Gottsegen National Cardiovascular Institute Academic / other |
| Locations | 1 site (Budapest) |
| Status | Recruiting |
| Started | August 17, 2026 |
| Main results expected | June 30, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07885618 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with ECMO and/or Impella support in the cardiovascular ICU who (or whose legal representative) can provide informed consent.
✕Probably not a fit
Patients not experiencing metabolic or thyroid disturbances related to critical illness may have limited direct benefit from this observational work.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center observational study follows adults treated with temporary mechanical circulatory support (ECMO or Impella) to see how metabolic status and thyroid hormone dynamics relate to 28-day and ICU mortality and other outcomes. Researchers collect medical history, nutritional status, functional capacity, and serial laboratory data including thyroid axis hormones, blood gases, and coagulation profiles. The aim is to identify independent predictors of mortality and characterize cardiac and non-cardiac complications and nutritional changes during critical illness. The study emphasizes non-cardiac factors such as endocrine dysfunction and nutritional status as potential drivers of outcomes in severe cardiogenic shock. Enrollment includes consecutive eligible patients with consent, making this a real-world cohort assessment in a high-volume center.
Why it matters
Potential benefit: If successful, findings could help clinicians identify at-risk patients earlier and tailor supportive care to improve survival and recovery.
How similar studies have gone: Previous work in critical illness has shown that non-cardiac factors like endocrine changes and nutritional status can influence outcomes, but studies in ECMO/Impella settings are less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (age ≥ 18 years) * Treatment with ECMO and/or Impella support * Informed consent provided by the patients next of kin/ legal representative Exclusion Criteria: * None
Where it's running
-
Gottsegen Gyorgy National Cardiovascular Center
Budapest, Hungary Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation
This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.